Korean Gene Therapies On Horizon, But Slow Regulatory Changes A Drag

While Korean companies are actively pursuing development of gene therapies, various regulatory restrictions at home are keeping them from speeding up development. But global development continues apace, with interim Phase III results for some expected later this year.

Gene therapy
Korean Gene Therapy Trends And Regulatory Issues • Source: Shutterstock

South Korea is aiming to take a leading position in the globally blossoming gene therapy space, and around 20 clinical trials in this area are currently underway in the country, although there has been only one domestic approval so far amid various ongoing regulatory restrictions.

While the amount of clinical activity is increasing at home, local companies’ global programs appear to be progressing more rapidly,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia